Lactoferrin regulates sebogenesis and inflammation in SZ95 human sebocytes and mouse model of acne

Abstract

AbstractBackgroundThe aim of this study was to explore the anti‐inflammatory and anti‐lipid effects of lactoferrin on SZ95 human sebaceous gland cells and mouse model of acne.MethodsSZ95 cells were co‐cultured with different concentrations of lactoferrin, and cell viability was determined using the 2,5‐diphenyl‐2H‐tetrazolium bromide method. Oil red O and Nile red staining were performed to determine the lipid content. The mRNA expression of genes related to lipid metabolism (sterol regulatory element‐binding protein‐1 [SREBP‐1], fatty acid synthase [FAS], stearoyl‐CoA desaturase‐1 [SCD‐1], fatty acid desaturase 2 [FADS2]) and inflammation (interleukin‐8 [IL‐8]) was determined by reverse transcription–polymerase chain reaction. An acne mouse model was established using injection of P. acnes on the backs of mice. The proliferation and apoptosis of sebaceous gland cells were examined by immunohistochemistry against proliferating cell nuclear antigen (PCNA) and TUNEL staining, respectively. Western blotting was used to detect FADS2 and CXCL15 protein expression.ResultsLactoferrin treatment at 10–500 μg/ml significantly decreased the lipid content, as revealed by the oil red O and Nile red staining. It also attenuated the increase of mRNA expression of SREBP‐1, FAS, SCD‐1, FADS2, and IL‐8 in insulin‐treated SZ95 cells. Moreover, lactoferrin treatment at the doses of 1–50 mg/mouse significantly reduced the inflammation and lipid production in the mouse model of acne. Also, the number of sebaceous gland cells was significantly reduced, and apoptosis was significantly increased by lactoferrin treatment in the mice. Mechanically, the levels of FADS2 and CXCL15 proteins in tissues were significantly decreased after lactoferrin treatment in the model mice.ConclusionOur results demonstrate the potential of lactoferrin against sebogenesis, sebaceous gland inflammation in acne.